Skip to main content
. 2021 Mar 12;9(2):e00743. doi: 10.1002/prp2.743

FIGURE 1.

FIGURE 1

Experimental setup. A CytoSorb® device was integrated in a custom‐made system, and serum containing remdesivir or GS‐441524, respectively, was circulated from a reservoir at a flow rate of 200 mL/min. Samples were taken from the circuit before (pre) and after (post) the adsorber device at 0, 5, 10, 15, 30, and 60 minutes for quantification of remdesivir or GS‐441524